drugset / Trial / NCT05153525

Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS

NCT05153525

Phase 4 Unknown 60 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this work is to compare continuous infusion vs on need intermittent boluses of Cisatracurium in the early management of pediatric acute respiratory distress syndrome

Timeline

Start
2022-01-06
Primary completion
2022-07-30
Completion
2022-08-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule 1 ug/kg Intravenous
Subject Cisatracurium Small molecule 0.1 mg/kg Intravenous
Subject Cisatracurium Small molecule 0.15 mg/kg Intravenous